These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 174379)

  • 1. GM2-gangliosidosis, AB variant: clinico-pathological study of a case.
    de Baecque CM; Suzuki K; Rapin I; Johnson AB; Whethers DL
    Acta Neuropathol; 1975 Dec; 33(3):207-26. PubMed ID: 174379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AB variant GM2 gangliosidosis: cerebrospinal fluid and neuropathologic characteristics.
    Kotagal S; Wenger DA; Alcala H; Gomez C; Horenstein S
    Neurology; 1986 Mar; 36(3):438-40. PubMed ID: 3081832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The so-called amaurotic idiocies. Clinical, morphological and biochemical findings as a basis for modern classification].
    Minauf M
    Veroff Pathol; 1975; 96():1-89. PubMed ID: 180723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult (chronic) GM2 gangliosidosis. Atypical spinocerebellar degeneration in a Jewish sibship.
    Rapin I; Suzuki K; Suzuki K; Valsamis MP
    Arch Neurol; 1976 Feb; 33(2):120-30. PubMed ID: 175770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naturally occurring GM2 gangliosidosis in two Muntjak deer with pathological and biochemical features of human classical Tay-Sachs disease (type B GM2 gangliosidosis).
    Fox J; Li YT; Dawson G; Alleman A; Johnsrude J; Schumacher J; Homer B
    Acta Neuropathol; 1999 Jan; 97(1):57-62. PubMed ID: 9930895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases.
    Huang JQ; Trasler JM; Igdoura S; Michaud J; Hanal N; Gravel RA
    Hum Mol Genet; 1997 Oct; 6(11):1879-85. PubMed ID: 9302266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The AB-variant of GM2-gangliosidosis. Clinical, biochemical, and pathological studies of two patients.
    Goldman JE; Yamanaka T; Rapin I; Adachi M; Suzuki K; Suzuki K
    Acta Neuropathol; 1980; 52(3):189-202. PubMed ID: 6255724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies.
    Tsuji D; Higashine Y; Matsuoka K; Sakuraba H; Itoh K
    Clin Chim Acta; 2007 Mar; 378(1-2):38-41. PubMed ID: 17196574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase and asialo GM2 (GA2) N-acetyl-beta-D-galactosaminidase; studies in human skin fibroblasts.
    O'Brien JS; Norden GW; Miller AL; Frost RG; Kelly TE
    Clin Genet; 1977 Mar; 11(3):171-83. PubMed ID: 13950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of GM2-gangliosidosis (Tay-Sachs and Sandhoff disease) gene carriers by serum hexosaminidase assay.
    Molzer B; Bernheimer H
    Clin Chim Acta; 1976 Nov; 73(1):163-9. PubMed ID: 826357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse model of GM2 activator deficiency manifests cerebellar pathology and motor impairment.
    Liu Y; Hoffmann A; Grinberg A; Westphal H; McDonald MP; Miller KM; Crawley JN; Sandhoff K; Suzuki K; Proia RL
    Proc Natl Acad Sci U S A; 1997 Jul; 94(15):8138-43. PubMed ID: 9223328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported.
    Maegawa GH; Stockley T; Tropak M; Banwell B; Blaser S; Kok F; Giugliani R; Mahuran D; Clarke JT
    Pediatrics; 2006 Nov; 118(5):e1550-62. PubMed ID: 17015493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine structure of cutaneous nerves in ganglioside storage disease.
    Dolman CL; MacLeod PM; Chang E
    J Neurol Neurosurg Psychiatry; 1977 Jun; 40(6):588-94. PubMed ID: 198513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tay-Sachs disease with conspicuous cranial computerized tomographic appearances.
    Watanabe K; Mukawa A; Muto K; Nishikawa J; Takahashi S
    Acta Pathol Jpn; 1985 Nov; 35(6):1521-32. PubMed ID: 2936060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gangliosidoses.
    Volk BW; Adachi M; Schneck L
    Hum Pathol; 1975 Sep; 6(5):555-69. PubMed ID: 170187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
    Charrow J; Binns HJ
    Clin Chim Acta; 1986 Apr; 156(1):41-9. PubMed ID: 2938852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2.
    Conzelmann E; Sandhoff K
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3979-83. PubMed ID: 99746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine Sialidase Neu3 facilitates GM2 degradation and bypass in mouse model of Tay-Sachs disease.
    Seyrantepe V; Demir SA; Timur ZK; Von Gerichten J; Marsching C; Erdemli E; Oztas E; Takahashi K; Yamaguchi K; Ates N; Dönmez Demir B; Dalkara T; Erich K; Hopf C; Sandhoff R; Miyagi T
    Exp Neurol; 2018 Jan; 299(Pt A):26-41. PubMed ID: 28974375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation of ganglioside Gm2 in cerebrospinal fluid of a patient with the variant AB of infantile Gm2 gangliosidosis.
    Pullarkat RK; Reha H; Beratis NG
    Pediatrics; 1981 Jul; 68(1):106-8. PubMed ID: 7243492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of the hexosaminidase A activator protein in a case of GM2 gangliosidosis; variant AB.
    Hechtman P; Gordon BA; Ng Ying Kin NM
    Pediatr Res; 1982 Mar; 16(3):217-22. PubMed ID: 6801612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.